Cargando…
Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies
Metformin is a first-line drug for type 2 diabetes, and its anticancer effects have also been widely studied in recent years. The Sonic hedgehog (Shh) signaling pathway is involved in the initiation and progression of medulloblastoma. In order to develop a new treatment strategy for medulloblastoma...
Autores principales: | Fang, Huangyi, Wang, Lingfei, Yu, Lisheng, Shen, Fang, Yang, Zelin, Yang, Yue, Li, Shize, Dai, Haipeng, Tan, Feng, Lin, Jian, Sheng, Hansong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585190/ https://www.ncbi.nlm.nih.gov/pubmed/36278239 http://dx.doi.org/10.3389/fphar.2022.928853 |
Ejemplares similares
-
Generating a mouse model for relapsed Sonic Hedgehog medulloblastoma
por: Heller, Allie, et al.
Publicado: (2023) -
Liposome-Imipramine Blue Inhibits Sonic Hedgehog Medulloblastoma In Vivo
por: MacDonald, Tobey J., et al.
Publicado: (2021) -
Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179
por: Li, Yuchen, et al.
Publicado: (2023) -
Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma
por: Jenkins, Noah C, et al.
Publicado: (2014) -
HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
por: Bell, Jonathan B., et al.
Publicado: (2018)